Concepedia

Author

Pavithra Viswanath

University of California, San FranciscoORCID

Also Known As

P. S. Viswanath, P. Viswanath, Pavithra Viswanath

143

Publications

1.4K

Citations

24

H-Index

43

Concepts

All Affiliations

University of California, San FranciscoNeurological SurgeryUniversity of California SystemUCSF Helen Diller Family Comprehensive Cancer CenterUniversity of Calgary
PV

About

Pavithra Viswanath is an author at University of California, San Francisco specializing in biochemistry, medicine, and metabolic regulation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

149

2

Education

1

1

30

3

Engineering

1

1

30

4

Health Sciences

1

1

120

5

Natural Sciences

1

1

29

Pavithra Viswanath

×

27

Publications

1.3K

Citations

22

H-Index

YearCitations

Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>

Tali Mazor, Charles Chesnelong, Aleksandr Pankov,

Proceedings of the National Academy of Sciences

2017

139

<i>IDH1</i> Mutation Induces Reprogramming of Pyruvate Metabolism

José Luis Izquierdo-García, Pavithra Viswanath, Pia Eriksson,

Cancer Research

2015

120

Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis

Tor-Christian Aase Johannessen, Joydeep Mukherjee, Pavithra Viswanath,

Molecular Cancer Research

2016

110

Metabolic Reprogramming in Mutant IDH1 Glioma Cells

José Luis Izquierdo-García, Pavithra Viswanath, Pia Eriksson,

PLoS ONE

2015

78

Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate

Shahul Hameed P, Suresh Solapure, Vikas Patil,

Nature Communications

2015

73

Hyperpolarized 13C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring

Myriam M. Chaumeil, Marina Radoul, Chloé Najac,

NeuroImage Clinical

2016

66

PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

Georgios Batsios, Pavithra Viswanath, Elavarasan Subramani,

Scientific Reports

2019

62

Mutant IDH1 Expression Drives <i>TERT</i> Promoter Reactivation as Part of the Cellular Transformation Process

Shigeo Ohba, Joydeep Mukherjee, Tor-Christian Aase Johannessen,

Cancer Research

2016

61

Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies

Ning Zhao, Yangjie Huang, Yung-Hua Wang,

Journal of Nuclear Medicine

2020

54

2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas

Pavithra Viswanath, Marina Radoul, José Luis Izquierdo-García,

Cancer Research

2018

48

Page 1